Clay B. Siegall, President and CEO at Immunome Inc. (IMNM), bought 137,100 shares at $7.29 ($999K) on 2025-03-26, disclosed to the SEC on 2025-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMNM | BUY | 2025-12-30 | $200K | — | Filing → |
| IMNM | BUY | 2025-12-22 | $298K | — | Filing → |
| IMNM | BUY | 2025-12-18 | $2.0M | — | Filing → |